Swisher EM - Search Results

1

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.

AlHilli MM, Becker MA, Weroha SJ, Flatten KS, Hurley RM, Harrell MI, Oberg AL, Maurer MJ, Hawthorne KM, Hou X, Harrington SC, McKinstry S, Meng XW, Wilcoxen KM, Kalli KR, Swisher EM, Kaufmann SH, Haluska P. AlHilli MM, et al. Among authors: swisher em. Gynecol Oncol. 2016 Nov;143(2):379-388. doi: 10.1016/j.ygyno.2016.08.328. Epub 2016 Sep 8. Gynecol Oncol. 2016. PMID: 27614696 Free PMC article.

2

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA. Paley PJ, et al. Among authors: swisher em. Gynecol Oncol. 2001 Feb;80(2):176-80. doi: 10.1006/gyno.2000.6071. Gynecol Oncol. 2001. PMID: 11161856

3

Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.

Herzog TJ, Kowalski LD, Liu H, Arlt M, Swisher E. Herzog TJ, et al. Gynecol Oncol. 2001 Jul;82(1):139-42. doi: 10.1006/gyno.2001.6230. Gynecol Oncol. 2001. PMID: 11426975

4

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Leeper K, et al. Gynecol Oncol. 2002 Oct;87(1):52-6. doi: 10.1006/gyno.2002.6779. Gynecol Oncol. 2002. PMID: 12468342

5

Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.

Shah C, Johnson EB, Everett E, Tamimi H, Greer B, Swisher E, Goff B. Shah C, et al. Gynecol Oncol. 2005 Dec;99(3):564-70. doi: 10.1016/j.ygyno.2005.06.011. Epub 2005 Oct 24. Gynecol Oncol. 2005. PMID: 16246402

6

The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Tamimi H, Goff B. Lachance JA, et al. Gynecol Oncol. 2006 Jun;101(3):470-5. doi: 10.1016/j.ygyno.2005.11.009. Epub 2006 Jan 18. Gynecol Oncol. 2006. PMID: 16413048

7

Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma.

Garg R, Wollan M, Galic V, Garcia R, Goff BA, Gray HJ, Swisher E. Garg R, et al. Gynecol Oncol. 2006 Dec;103(3):793-6. doi: 10.1016/j.ygyno.2006.08.043. Epub 2006 Oct 4. Gynecol Oncol. 2006. PMID: 17023036 Free PMC article.

8

Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.

Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Shah CA, et al. Among authors: swisher em. Gynecol Oncol. 2008 May;109(2):215-9. doi: 10.1016/j.ygyno.2008.01.010. Epub 2008 Mar 7. Gynecol Oncol. 2008. PMID: 18314181

9

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

Feng Q, Deftereos G, Hawes SE, Stern JE, Willner JB, Swisher EM, Xi L, Drescher C, Urban N, Kiviat N. Feng Q, et al. Among authors: swisher em. Gynecol Oncol. 2008 Nov;111(2):320-9. doi: 10.1016/j.ygyno.2008.07.036. Epub 2008 Aug 30. Gynecol Oncol. 2008. PMID: 18757082 Free PMC article.

10

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.

Norquist B, Wurz KA, Pennil CC, Garcia R, Gross J, Sakai W, Karlan BY, Taniguchi T, Swisher EM. Norquist B, et al. Among authors: swisher em. J Clin Oncol. 2011 Aug 1;29(22):3008-15. doi: 10.1200/JCO.2010.34.2980. Epub 2011 Jun 27. J Clin Oncol. 2011. PMID: 21709188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters